(BCS) Barclays - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US06738E2046
Stock: Retail Banking, Credit Cards, Investment Banking, Wealth Management, Lending
Total Rating 42
Risk 64
Buy Signal 0.12
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.53% |
| Yield on Cost 5y | 6.36% |
| Yield CAGR 5y | 27.16% |
| Payout Consistency | 89.4% |
| Payout Ratio | 23.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.0% |
| Relative Tail Risk | 3.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.85 |
| Alpha | 65.62 |
| Character TTM | |
|---|---|
| Beta | 1.096 |
| Beta Downside | 1.239 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.97% |
| CAGR/Max DD | 1.70 |
Description: BCS Barclays January 27, 2026
Barclays PLC (NYSE: BCS) is a globally diversified financial services firm headquartered in London, operating across retail banking, credit cards, wholesale and investment banking, wealth management, and investment management. Its business is organized into five segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank & Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank.
In its latest reporting (Q4 2025), Barclays posted a net profit of $5.9 billion, a 7% year-over-year increase, driven by a 4% rise in loan book growth and a 12% lift in fee-based income. The bank’s Common Equity Tier 1 (CET1) ratio improved to 13.2%, reflecting a stronger capital position amid tightening European banking regulations. Key sector drivers include the Bank of England’s policy rate at 5.25%-supporting net interest margins-and accelerating digital adoption, with 55% of UK retail transactions now processed via mobile channels, outpacing the industry average of 48%.
For a deeper quantitative assessment, explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 6.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.51 > 1.0 |
| NWC/Revenue: -809.9% < 20% (prev -820.9%; Δ 10.96% < -1%) |
| CFO/TA 0.02 > 3% & CFO 27.41b > Net Income 6.91b |
| Net Debt (-252.57b) to EBITDA (9.53b): -26.49 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.51b) vs 12m ago -4.12% < -2% |
| Gross Margin: 6.97% > 18% (prev 0.09%; Δ 687.9% > 0.5%) |
| Asset Turnover: 1.73% > 50% (prev 1.60%; Δ 0.13% > 0%) |
| Interest Coverage Ratio: -0.01 > 6 (EBITDA TTM 9.53b / Interest Expense TTM 25.39b) |
Altman Z'' -0.72
| A: -0.14 (Total Current Assets 867.76b - Total Current Liabilities 1088.80b) / Total Assets 1629.15b |
| B: 0.04 (Retained Earnings 58.37b / Total Assets 1629.15b) |
| C: -0.00 (EBIT TTM -219.0m / Avg Total Assets 1580.14b) |
| D: 0.05 (Book Value of Equity 76.39b / Total Liabilities 1552.31b) |
| Altman-Z'' Score: -0.72 = B |
What is the price of BCS shares?
As of February 07, 2026, the stock is trading at USD 26.41 with a total of 5,846,459 shares traded.
Over the past week, the price has changed by -1.27%, over one month by +0.61%, over three months by +22.33% and over the past year by +77.47%.
Over the past week, the price has changed by -1.27%, over one month by +0.61%, over three months by +22.33% and over the past year by +77.47%.
Is BCS a buy, sell or hold?
Barclays has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.3 | -11.9% |
| Analysts Target Price | 23.3 | -11.9% |
| ValueRay Target Price | 37.4 | 41.5% |
BCS Fundamental Data Overview February 07, 2026
Market Cap GBP = 64.39b (87.88b USD * 0.7327 USD.GBP)
P/E Trailing = 11.4775
P/E Forward = 8.726
P/S = 3.3781
P/B = 0.84
P/EG = 1.3221
Revenue TTM = 27.29b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 121.50b GBP (from longTermDebt, last quarter)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -659.17b GBP (64.39b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
EV/FCF = -119.0x (Enterprise Value -659.17b / FCF TTM 5.54b)
FCF Yield = -0.84% (FCF TTM 5.54b / Enterprise Value -659.17b)
FCF Margin = 20.30% (FCF TTM 5.54b / Revenue TTM 27.29b)
Net Margin = 25.33% (Net Income TTM 6.91b / Revenue TTM 27.29b)
Gross Margin = 6.97% ((Revenue TTM 27.29b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.40 (set to none) (Enterprise Value -659.17b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.11% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 121.50b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.12% (E(64.39b)/V(208.38b) * Re(9.95%) + D(143.98b)/V(208.38b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 51.06% ; FCFF base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 78.35 (EV 17.67b - Net Debt -252.57b = Equity 270.24b / Shares 3.45b; r=13.12% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -1.29 | EPS CAGR: -47.09% | SUE: -3.21 | # QB: 0
Revenue Correlation: 42.33 | Revenue CAGR: 8.98% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.92 | Chg30d=+0.073 | Revisions Net=+1 | Growth EPS=+22.4% | Growth Revenue=+5.4%
P/E Trailing = 11.4775
P/E Forward = 8.726
P/S = 3.3781
P/B = 0.84
P/EG = 1.3221
Revenue TTM = 27.29b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 121.50b GBP (from longTermDebt, last quarter)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -659.17b GBP (64.39b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
EV/FCF = -119.0x (Enterprise Value -659.17b / FCF TTM 5.54b)
FCF Yield = -0.84% (FCF TTM 5.54b / Enterprise Value -659.17b)
FCF Margin = 20.30% (FCF TTM 5.54b / Revenue TTM 27.29b)
Net Margin = 25.33% (Net Income TTM 6.91b / Revenue TTM 27.29b)
Gross Margin = 6.97% ((Revenue TTM 27.29b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.40 (set to none) (Enterprise Value -659.17b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.11% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 121.50b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.12% (E(64.39b)/V(208.38b) * Re(9.95%) + D(143.98b)/V(208.38b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 51.06% ; FCFF base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 78.35 (EV 17.67b - Net Debt -252.57b = Equity 270.24b / Shares 3.45b; r=13.12% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -1.29 | EPS CAGR: -47.09% | SUE: -3.21 | # QB: 0
Revenue Correlation: 42.33 | Revenue CAGR: 8.98% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.92 | Chg30d=+0.073 | Revisions Net=+1 | Growth EPS=+22.4% | Growth Revenue=+5.4%